Snowden Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$661K Sell
13,373
-943
-7% -$47.9K 0.02% 720
2026
Q1
$764K Sell
14,316
-3,688
-20% -$217K 0.02% 615
2025
Q4
$1.12M Sell
18,004
-3,312
-16% -$204K 0.03% 494
2025
Q3
$1.28M Sell
21,316
-1,608
-7% -$98.4K 0.04% 447
2025
Q2
$1.44M Sell
22,924
-111
-0.5% -$6.67K 0.04% 410
2025
Q1
$1.39M Buy
23,035
+1,794
+8% +$111K 0.04% 404
2024
Q4
$1.24M Buy
21,241
+1,052
+5% +$62.5K 0.04% 435
2024
Q3
$1.2M Sell
20,189
-1,240
-6% -$70.8K 0.04% 464
2024
Q2
$1.2M Buy
21,429
+1,613
+8% +$90.3K 0.04% 456
2024
Q1
$1.16M Buy
19,816
+5,290
+36% +$299K 0.04% 463
2023
Q4
$784K Sell
14,526
-19,583
-57% -$957K 0.03% 505
2023
Q3
$1.65M Sell
34,109
-21,858
-39% -$1.16M 0.07% 304
2023
Q2
$3.16M Sell
55,967
-7,231
-11% -$398K 0.11% 225
2023
Q1
$3.41M Sell
63,198
-3,015
-5% -$161K 0.13% 199
2022
Q4
$3.48M Sell
66,213
-875
-1% -$44.4K 0.15% 175
2022
Q3
$3.17M Sell
67,088
-3,751
-5% -$195K 0.14% 184
2022
Q2
$3.57M Sell
70,839
-7,203
-9% -$393K 0.16% 170
2022
Q1
$4.76M Buy
78,042
+5,388
+7% +$321K 0.19% 145
2021
Q4
$4.78M Sell
72,654
-1,477
-2% -$94.6K 0.24% 119
2021
Q3
$4.65M Sell
74,131
-9,383
-11% -$599K 0.23% 126
2021
Q2
$5.03M Sell
83,514
-5,478
-6% -$317K 0.25% 114
2021
Q1
$4.9M Sell
88,992
-13,608
-13% -$755K 0.28% 100
2020
Q4
$5.6M Buy
102,600
+18,030
+21% +$942K 0.37% 68
2020
Q3
$4.22M Buy
84,570
+21,300
+34% +$1.03M 0.34% 85
2020
Q2
$2.79M Buy
63,270
+23,634
+60% +$1.01M 0.24% 136
2020
Q1
$1.49M Sell
39,636
-690
-2% -$29.1K 0.16% 191
2019
Q4
$1.78M Sell
40,326
-15,894
-28% -$668K 0.16% 192
2019
Q3
$2.32M Buy
56,220
+1,488
+3% +$60.9K 0.23% 147
2019
Q2
$2.2M Sell
54,732
-66
-0.1% -$2.5K 0.23% 155
2019
Q1
$2.11M Buy
54,798
+348
+0.6% +$12.6K 0.23% 152
2018
Q4
$1.81M Buy
54,450
+1,212
+2% +$42K 0.24% 154
2018
Q3
$2.02M Buy
53,238
+438
+0.8% +$15.6K 0.23% 143
2018
Q2
$1.77M Buy
52,800
+1,494
+3% +$48.7K 0.23% 152
2018
Q1
$1.58M Buy
51,306
+1,704
+3% +$52.5K 0.23% 159
2017
Q4
$1.43M Buy
49,602
+2,298
+5% +$66.3K 0.21% 168
2017
Q3
$1.32M Buy
47,304
+2,028
+4% +$56.1K 0.21% 154
2017
Q2
$1.26M Buy
45,276
+2,394
+6% +$63.4K 0.24% 138
2017
Q1
$1.08M Buy
+42,882
New +$1.04M 0.24% 146

Other funds holding IHI

Snowden Capital Advisors's IHI Position: Q2 2026 in Review

Snowden Capital Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 6.6% in Q2 2026, selling an estimated $47.9K and leaving 13,373 shares worth $661K. The position accounts for 0.02% of the portfolio, ranked #720.

Snowden Capital Advisors first reported a position in IHI in Q1 2017 and has held it in 38 quarters since. The position peaked at $5.6M in Q4 2020. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Snowden Capital Advisors held 13,373 shares of iShares US Medical Devices ETF worth $661K as of Q2 2026.
  • Snowden Capital Advisors sold 943 iShares US Medical Devices ETF shares in Q2 2026, an estimated $47.9K.
  • iShares US Medical Devices ETF made up 0.02% of Snowden Capital Advisors's portfolio in Q2 2026, its #720 holding.
  • Snowden Capital Advisors first reported a position in iShares US Medical Devices ETF in Q1 2017 and has held it in 38 quarters since.
  • Snowden Capital Advisors's iShares US Medical Devices ETF position peaked at $5.6M in Q4 2020.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.